Total Payments
$73,770
2024 Payments
$16,947
Companies
33
Transactions
442
Medicare Patients
19,552
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$35,987 (48.8%)
Education$27,656 (37.5%)
Food & Beverage$5,626 (7.6%)
Consulting$4,502 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $35,987 | 8 | 48.8% |
| Education | $27,656 | 20 | 37.5% |
| Food and Beverage | $5,626 | 412 | 7.6% |
| Consulting Fee | $4,502 | 2 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $63,783 | 20 | $0 (2024) |
| Roche Diagnostics Corporation | $2,750 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $2,221 | 31 | $0 (2024) |
| Novo Nordisk Inc | $1,120 | 94 | $0 (2024) |
| ABBVIE INC. | $728.50 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $619.60 | 45 | $0 (2024) |
| Lilly USA, LLC | $497.05 | 45 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $393.57 | 39 | $0 (2022) |
| PFIZER INC. | $306.39 | 28 | $0 (2022) |
| Allergan, Inc. | $245.36 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,947 | 14 | AngioDynamics, Inc. ($16,787) |
| 2023 | $9,818 | 15 | AngioDynamics, Inc. ($9,600) |
| 2022 | $9,994 | 29 | AngioDynamics, Inc. ($9,625) |
| 2021 | $10,360 | 60 | AngioDynamics, Inc. ($9,652) |
| 2020 | $8,774 | 33 | AngioDynamics, Inc. ($5,644) |
| 2019 | $7,556 | 69 | AngioDynamics, Inc. ($4,800) |
| 2018 | $5,822 | 76 | AngioDynamics, Inc. ($4,849) |
| 2017 | $4,500 | 146 | AngioDynamics, Inc. ($2,827) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,333.33 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $2,853.33 | General |
| Category: ET | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Endocrinology | ||||||
| 03/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/31/2023 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $4,800.00 | General |
| Category: ET | ||||||
| 12/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Gastroenterology | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 64 | 4,639 | 8,530 | $1.3M | $555,730 |
| 2022 | 63 | 3,825 | 7,494 | $1.1M | $454,900 |
| 2021 | 71 | 5,399 | 12,148 | $1.8M | $637,501 |
| 2020 | 69 | 5,689 | 11,398 | $1.7M | $585,166 |
Total Patients
19,552
Total Services
39,570
Medicare Billing
$2.2M
Procedure Codes
267
All Medicare Procedures & Services
267 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 337 | 750 | $212,716 | $79,289 | 37.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 411 | 1,094 | $97,388 | $57,796 | 59.3% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 212 | 220 | $134,514 | $51,463 | 38.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 279 | 832 | $67,858 | $34,019 | 50.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 429 | $65,500 | $28,701 | 43.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 178 | 543 | $67,240 | $24,766 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 206 | 322 | $64,461 | $24,406 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 117 | 117 | $33,857 | $16,637 | 49.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 68 | 327 | $36,402 | $13,799 | 37.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 45 | 45 | $25,534 | $12,691 | 49.7% |
| 94621 | Test for exercise-induced heart and lung stress | Office | 2023 | 72 | 72 | $25,699 | $9,563 | 37.2% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 154 | $14,815 | $9,507 | 64.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 85 | $24,424 | $8,807 | 36.1% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 59 | 75 | $15,114 | $8,773 | 58.0% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 72 | 72 | $19,723 | $8,515 | 43.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 63 | 83 | $18,876 | $8,136 | 43.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 81 | 83 | $25,232 | $8,111 | 32.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 75 | 75 | $22,932 | $8,056 | 35.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 113 | 138 | $18,772 | $7,156 | 38.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 45 | 152 | $21,888 | $6,867 | 31.4% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 72 | 72 | $17,426 | $6,742 | 38.7% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 52 | 52 | $19,777 | $6,621 | 33.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 94 | 97 | $19,076 | $6,592 | 34.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 64 | $14,042 | $6,456 | 46.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 45 | 57 | $15,725 | $6,133 | 39.0% |
About Dr. Alexander Salerno, MD
Dr. Alexander Salerno, MD is a Internal Medicine healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962476903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Salerno, MD has received a total of $73,770 in payments from pharmaceutical and medical device companies, with $16,947 received in 2024. These payments were reported across 442 transactions from 33 companies. The most common payment nature is "Long term medical supply or device loan" ($35,987).
As a Medicare-enrolled provider, Salerno has provided services to 19,552 Medicare beneficiaries, totaling 39,570 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 267 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Orange, NJ
- Active Since 02/15/2006
- Last Updated 07/13/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962476903
Products in Payments
- VenaCure 1470 Pro (Device) $45,639
- EVLT (Device) $18,027
- POC cobas Liat Analyzer, Assays, Controls and Accessories (Device) $2,750
- Ozempic (Drug) $423.63
- ENTRESTO (Drug) $399.25
- VRAYLAR (Drug) $396.18
- JARDIANCE (Drug) $341.91
- TRELEGY ELLIPTA (Drug) $269.89
- Victoza (Drug) $261.29
- TRULICITY (Drug) $208.83
- UBRELVY (Drug) $200.00
- ANORO (Drug) $150.65
- INVOKANA (Drug) $131.88
- FARXIGA (Drug) $110.79
- Tresiba (Drug) $109.61
- CHANTIX (Drug) $107.73
- Mavyret (Drug) $101.77
- Xultophy 100/3.6 (Drug) $79.22
- VIBERZI (Drug) $78.53
- Amitiza (Drug) $75.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Orange
Dr. Gitendra Rajiyah, Md, MD
Internal Medicine — Payments: $20,111
Internal Medicine $20,111
Eddy Simon, Md, MD
Internal Medicine — Payments: $7,943
Internal Medicine $7,943
Dr. Anand Srinivasan, Md, MD
Internal Medicine — Payments: $7,905
Internal Medicine $7,905
Dr. Radhika Maddali, Md, MD
Internal Medicine — Payments: $6,737
Internal Medicine $6,737
Dr. Mamatha Mohan, M.d, M.D
Internal Medicine — Payments: $6,050
Internal Medicine $6,050
Robert Clarke, Md, MD
Internal Medicine — Payments: $5,522
Internal Medicine $5,522